| Active Ingredient | Fenbendazole |
| Manufacturer | Kachhela Medex Pvt. Ltd. |
| Packaging | 10 Tablets in 1 strip |
| Strength | 444 Mg |
| Delivery Time | 14-16 Days |
| SKU | 13 |
| Pack | Price | Qty | Add |
|---|---|---|---|
| 100 Tablets | $140.00 | ||
| 300 Tablets | $250.00 | ||
| 500 Tablets | $370.00 | ||
| 1000 Tablets | $650.00 |
Fenbendazole 444 mg tablets are a benzimidazole-class antiparasitic compound with several decades of established use in veterinary medicine. It is used to treat parasitic worm infections in animals including dogs, cats, livestock, and other species.
It acts against several types of parasitic organisms including roundworms, hookworms, whipworms, and certain tapeworm species when used in appropriate veterinary contexts.
Fenbendazole is not currently approved by the U.S. Food and Drug Administration (FDA) for use in humans. Any consideration of use in humans must be discussed with and directly supervised by a licensed healthcare professional.
Kachella Medex is a pharmaceutical manufacturer producing this Fenbendazole formulation in compliance with applicable pharmaceutical manufacturing quality standards.
Fenbendazole 444 mg works by binding to a structural protein called beta-tubulin found within susceptible parasitic organisms. Beta-tubulin is a fundamental building block that parasites depend on to form microtubules — internal cellular structures essential for nutrient absorption, energy metabolism, and cell division.
When Fenbendazole binds to beta-tubulin, it disrupts the formation of these microtubules. Without functional microtubules, the parasite loses its ability to absorb glucose for energy, cannot divide properly, and gradually loses cellular integrity.
This selective mechanism works because Fenbendazole has a much stronger binding affinity for parasitic beta-tubulin compared to mammalian beta-tubulin, which forms the basis of its antiparasitic selectivity in established veterinary use.
In its established veterinary application, Fenbendazole 444 mg offers broad-spectrum antiparasitic activity against multiple parasite types in animals, a well-documented veterinary safety profile across multiple animal species, a convenient oral tablet form, and a long track record spanning several decades of veterinary use.
These points apply to established veterinary use only. No therapeutic benefits for human use are claimed or implied by MayoPills.
This product must not be self-administered without direct guidance from a qualified healthcare professional.
If this product has been recommended and supervised by a healthcare provider, follow their instructions precisely regarding dose amount, frequency, whether to take with or without food, duration of use, and any follow-up monitoring requirements.
Do not adjust the dose or duration of use without first consulting your healthcare provider.
There is no established or FDA-approved human dosage for Fenbendazole. In veterinary practice, dosage is determined by animal species, body weight, type of parasitic infection, and veterinarian assessment.
For any use considered under healthcare professional supervision, your provider will determine the appropriate amount, frequency, and duration based on your individual clinical circumstances.
Do not attempt to determine or adjust dosage independently based on veterinary references or unverified online sources.
Based on available information from veterinary use and limited human reports under medical supervision, the following side effects have been noted.
In veterinary use, gastrointestinal discomfort, nausea, vomiting, diarrhea, and temporary loss of appetite have been observed in some animals.
In limited human cases reported under medical supervision, nausea, stomach discomfort, elevated liver enzyme levels requiring monitoring, fatigue, and mild allergic skin reactions have been documented.
Seek immediate medical attention if you experience a severe allergic reaction including swelling, difficulty breathing, or hives, signs of liver involvement such as jaundice or dark urine, severe or persistent gastrointestinal symptoms, or any unexpected or worsening symptoms during use.
Regular monitoring by a healthcare professional is strongly recommended if this product is used under medical supervision.
Fenbendazole 444 mg is not FDA approved for human use and should only be considered under qualified medical supervision. Do not self-diagnose or self-treat any condition with this product.
Inform your healthcare provider about all existing medical conditions before any use. Disclose all medicines, supplements, and herbal products currently being taken. Liver function monitoring may be recommended by your healthcare provider during the period of use.
Safety during pregnancy and breastfeeding has not been established in humans. Inform your healthcare provider immediately if you are pregnant or planning to become pregnant before any use of this product.
Safety and appropriate use in children must be determined entirely by a qualified healthcare professional.
Limited formal drug interaction data exists for Fenbendazole in humans. Based on currently available information, potential interactions may exist with other antiparasitic medicines where combined use may require careful medical assessment, medicines metabolized by liver enzymes where Fenbendazole may affect liver enzyme activity, and salicylanilide compounds where veterinary literature notes potential for enhanced adverse effects when used together.
Always inform your healthcare provider about every medicine, supplement, and herbal product you are currently taking before using this product.
Store Fenbendazole 444 mg Tablets at room temperature below 25°C or 77°F.
Keep out of reach of children and pets at all times. Do not use tablets past their expiry date. Dispose of any unused product following local pharmaceutical waste disposal regulations and guidelines.
Q: What is Fenbendazole 444 mg used for?
A: Fenbendazole is primarily a veterinary antiparasitic compound used to treat various parasitic worm infections in animals. It is not FDA-approved for human use. Any consideration of use must be under the direct supervision of a qualified healthcare professional.
Q: Is Fenbendazole approved for human use?
A: No. Fenbendazole does not currently hold FDA approval for any human medical indication. It is classified primarily as a veterinary medicine. It must not be used for self-treatment of any condition without direct medical supervision.
Q: Can I take Fenbendazole without consulting a doctor?
A: No. This product should never be used without the guidance and direct supervision of a qualified healthcare professional. Self-treatment with this product is not appropriate under any circumstances.
Q: What side effects should I be aware of?
A: Based on available information, side effects may include nausea, stomach discomfort, diarrhea, and elevated liver enzymes. Seek immediate medical attention for any severe or unexpected symptom. Regular monitoring is strongly recommended under medical supervision.
Q: Is Fenbendazole safe during pregnancy?
A: Safety during pregnancy has not been formally established in humans. Inform your healthcare provider immediately if you are pregnant or breastfeeding before any use of this product.
Q: What is the correct dose for humans?
A: There is no established FDA-approved human dosage for Fenbendazole. Only a qualified healthcare professional can determine any appropriate use and amount based on individual clinical circumstances.
Q: How should Fenbendazole 444 mg Tablets be stored?
A: Store at room temperature below 25°C, away from sunlight and moisture, in original packaging. Keep out of reach of children and pets at all times. Do not use past the expiry date printed on the packaging.
Medical Disclaimer: The information shown above is for educational purposes only. Please consult your doctor or a licensed healthcare professional before taking any medicine. Never start, stop, or change any treatment without professional medical advice.
Reviews
There are no reviews yet.